Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07196410Phase 1Recruiting
KAN-004 for Immune-Related Diarrhea or Colitis
ColitisDiarrhea Caused by Antitumor Drugs
PrincipalinvestigatorStart date: 2026-03-01
NCT06831539Phase 1Completed
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
CancerHealthy Participants
PrincipalinvestigatorStart date: 2024-12-05
NCT05303493Phase 1Completed
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma
Advanced Non-Small Cell Lung CancerMelanoma Stage IVNSCLC Stage IV+1 more
PrincipalinvestigatorStart date: 2022-06-29

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07196410Phase 1PrincipalInvestigator

KAN-004 for Immune-Related Diarrhea or Colitis

ColitisDiarrhea Caused by Antitumor Drugs
Recruiting
NCT06831539Phase 1PrincipalInvestigator

Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery

CancerHealthy Participants
Completed
NCT05303493Phase 1PrincipalInvestigator

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Advanced Non-Small Cell Lung CancerMelanoma Stage IVNSCLC Stage IV+1 more
Completed

All 3 trials loaded